Home » Prices » NASDAQ:AVRO

AVROBIO, Inc. stock price

Today's NASDAQ:AVRO chart, history & news

Price:
14.03 USD
Change:
+0.03 (0.21%)
Key Stats
Price open 14.13
Previous close 14
Market cap 511.41M
Volume 322.63K
Day high 14.23
Day low 13.81
Year high 27.21
Year low 10.08
Year to date change -30.09%
P/E Ratio N.A
Company Profile
Fundamentals
Insider Information
News

About AVROBIO, Inc.

Avrobio, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firms clinical-stage programs include Fabry disease, Gaucher disease and cystinosis . The company was founded by Geoff Mackay in 2015 and is headquartered in Cambridge, MA.

Company information

Company name
AvroBio Inc
Exchange
Sector
Health Technology
Industry
Biotechnology
CEO
Geoff MacKay
Address
One Kendall Square, Building 300 Suite 201, Cambridge, MA, 02139
Country
United States
Contact information
1.617.914.8420
Website
http://www.avrobio.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.